लोड हो रहा है...
Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
BACKGROUND: The benefit of chemotherapy in colon cancer patients is well documented but depends largely on whether patients complete the planned treatment regimen. We evaluated predictors of early discontinuation (EDChemo) and dose reduction of chemotherapy, especially the role of adverse treatment...
में बचाया:
| में प्रकाशित: | Ther Adv Med Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8072866/ https://ncbi.nlm.nih.gov/pubmed/33995589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211006348 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|